Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease

• Published in: Biomedicine & pharmacotherapy 2023-09, Vol.165, p.115024-115024, Article 115024
• Main Authors: Powis, Garth, Meuillet, Emmanuelle J., Indarte, Martin, Booher, Garrett, Kirkpatrick, Lynn
• Format: Article
• Language: English
• Subjects: Disease; Drugs; Mechanism; PH domain; Phosphatidylinositol; Pleckstrin
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2023.115024

The pleckstrin homology [PH] domain is a structural fold found in more than 250 proteins making it the 11th most common domain in the human proteome. 25% of family members have more than one PH domain and some PH domains are split by one, or several other, protein domains although still folding to give functioning PH domains. We review mechanisms of PH domain activity, the role PH domain mutation plays in human disease including cancer, hyperproliferation, neurodegeneration, inflammation, and infection, and discuss pharmacotherapeutic approaches to regulate PH domain activity for the treatment of human disease. Almost half PH domain family members bind phosphatidylinositols [PIs] that attach the host protein to cell membranes where they interact with other membrane proteins to give signaling complexes or cytoskeleton scaffold platforms. A PH domain in its native state may fold over other protein domains thereby preventing substrate access to a catalytic site or binding with other proteins. The resulting autoinhibition can be released by PI binding to the PH domain, or by protein phosphorylation thus providing fine tuning of the cellular control of PH domain protein activity. For many years the PH domain was thought to be undruggable until high-resolution structures of human PH domains allowed structure-based design of novel inhibitors that selectively bind the PH domain. Allosteric inhibitors of the Akt1 PH domain have already been tested in cancer patients and for proteus syndrome, with several other PH domain inhibitors in preclinical development for treatment of other human diseases. •The PH domain is a multifunctional 3D fold found in 11% of the human proteome.•Binding to phosphoinositides can translocate the host protein to cell membranes.•It can also promote adjacent domain activity or fold over to inhibit activity.•It plays a role in multiple human diseases often revealed by natural genetic mutation.•Several PH domain inhibitors are currently in development or clinical trials.